Skip to main content
. 2019 Mar 18;2019:9864841. doi: 10.1155/2019/9864841

Figure 3.

Figure 3

The PLS-DA score plot of therapeutic dose groups (A vs. B vs. C1 vs. C2) in ESI+ and ESI−. Healthy control group (A). AIA model group (B). Therapy group (C1). Efficacy enhancing combination group (C2).